Deriving Net Intrinsic Clearance With Uptake and Efflux

Why Uptake Does Not Equal Net Elimination

Drug entering a hepatocyte is not necessarily eliminated from the body. Some may be metabolized or exported into bile, but some may leave the cell across the basolateral membrane and return to blood. Under linear transport and quasi-steady intracellular conditions, net intrinsic clearance accounts for this competition: it is uptake clearance multiplied by the fraction of intracellular exit that is irreversible from the modeled parent-drug pool.

The derivation depends on distinguishing the direction and destination of each flux. Uptake moves parent drug from plasma into the hepatocyte. Basolateral efflux returns parent drug to blood. Metabolism and biliary export are treated here as irreversible removal from the intracellular parent-drug pool. The formula is not a claim that all uptake is elimination, nor does it itself calculate whole-liver clearance.

Definition: Let $C_{\mathrm{pl}}$ be plasma parent-drug concentration and $C_{\mathrm{cell}}$ be intracellular parent-drug concentration, expressed on a concentration basis compatible with the clearances below. Let $CL_{\mathrm{uptake}}$ denote linear uptake clearance from plasma to the intracellular pool; $CL_{\mathrm{efflux}}$, basolateral efflux clearance; $CL_{\mathrm{met}}$, metabolic clearance from that pool; and $CL_{\mathrm{bile}}$, biliary export clearance. Each clearance is defined so its flux equals that clearance multiplied by the concentration at the source of the flux. Thus uptake rate is $CL_{\mathrm{uptake}}C_{\mathrm{pl}}$, while the three intracellular exit rates are $CL_jC_{\mathrm{cell}}$. The net intrinsic clearance is the irreversible parent-drug removal rate divided by $C_{\mathrm{pl}}$, when $C_{\mathrm{pl}}>0$.

These clearances must use compatible units and concentration conventions. For example, if concentrations are in amount per volume, each clearance has units of volume per time and each clearance-times-concentration product has units of amount per time. The intracellular concentration convention must be the same for efflux, metabolism, and biliary export. A change of concentration basis requires corresponding changes to the clearance values.

Mass Balance and Quasi-Steady Derivation

Assume one well-mixed intracellular parent-drug pool of fixed volume $V_{\mathrm{cell}}$. Let the listed pathways be the only fluxes into or out of this pool. With linear kinetics, the intracellular amount changes according to uptake minus all three exits:

\frac{dA_{\mathrm{cell}}}{dt} = CL_{\mathrm{uptake}}C_{\mathrm{pl}} - \left(CL_{\mathrm{efflux}}+CL_{\mathrm{met}}+CL_{\mathrm{bile}}\right)C_{\mathrm{cell}}, \qquad A_{\mathrm{cell}}=V_{\mathrm{cell}}C_{\mathrm{cell}}.

Quasi-steady intracellular conditions mean that the intracellular amount changes negligibly over the time interval of interest, so the left side is set to zero. This approximation is appropriate when intracellular adjustment is fast relative to meaningful changes in plasma concentration or pathway activity. It is not the same as asserting that the whole organism is at steady state.

Write $CL_{\mathrm{exit}}=CL_{\mathrm{efflux}}+CL_{\mathrm{met}}+CL_{\mathrm{bile}}$. If $CL_{\mathrm{exit}}>0$, the quasi-steady balance gives:

CL_{\mathrm{uptake}}C_{\mathrm{pl}}=CL_{\mathrm{exit}}C_{\mathrm{cell}}, \qquad \frac{C_{\mathrm{cell}}}{C_{\mathrm{pl}}} = \frac{CL_{\mathrm{uptake}}}{CL_{\mathrm{exit}}}.

The irreversible removal rate from the intracellular parent pool is the sum of the metabolic and biliary rates. Basolateral efflux is excluded because it returns parent drug to blood in this model. Dividing the irreversible removal rate by plasma concentration and substituting the quasi-steady intracellular concentration gives the central result.

Theorem: Suppose uptake, efflux, metabolism, and biliary export are linear; there is one intracellular parent-drug pool; the clearances use compatible concentration definitions; the listed fluxes are the only relevant inputs and exits; and intracellular conditions are quasi-steady. If $C_{\mathrm{pl}}>0$ and $CL_{\mathrm{efflux}}+CL_{\mathrm{met}}+CL_{\mathrm{bile}}>0$, then $$ CL_{\mathrm{int,net}} = \frac{(CL_{\mathrm{met}}+CL_{\mathrm{bile}})C_{\mathrm{cell}}}{C_{\mathrm{pl}}} = CL_{\mathrm{uptake}} \frac{CL_{\mathrm{met}}+CL_{\mathrm{bile}}} {CL_{\mathrm{efflux}}+CL_{\mathrm{met}}+CL_{\mathrm{bile}}}. $$ Here $CL_{\mathrm{int,net}}$ is net intrinsic clearance with respect to plasma concentration. The fraction in the formula is the fraction of total intracellular exit attributable to metabolism or biliary export.

The condition $C_{\mathrm{pl}}>0$ matters because the definition divides the removal rate by plasma concentration. At $C_{\mathrm{pl}}=0$, that ratio is not defined, even though the algebraic expression on the right might have a numerical value. One could instead define a linear clearance coefficient by its response to concentration, but the result above uses the rate-divided-by-concentration definition and states its domain explicitly.

Worked Consequences of the Formula

Worked Example: Uptake Split Between Efflux and Irreversible Loss

Suppose a hypothetical system has $CL_{\mathrm{uptake}}=18$ L/h, $CL_{\mathrm{efflux}}=12$ L/h, $CL_{\mathrm{met}}=20$ L/h, and $CL_{\mathrm{bile}}=4$ L/h. Let $C_{\mathrm{pl}}=1.5$ mg/L. Assume the pathways are linear, the concentration bases are compatible, and intracellular conditions are quasi-steady. The total exit clearance is $12+20+4=36$ L/h, which is positive.

First calculate the intracellular-to-plasma concentration ratio:

\frac{C_{\mathrm{cell}}}{C_{\mathrm{pl}}} = \frac{18}{36} =0.5000, \qquad C_{\mathrm{cell}}=0.5000(1.5)=0.7500\ \mathrm{mg/L}.

The irreversible removal rate is $(20+4)(0.7500)=18.00$ mg/h. Therefore:

CL_{\mathrm{int,net}} = \frac{18.00\ \mathrm{mg/h}}{1.5\ \mathrm{mg/L}} =12.00\ \mathrm{L/h}.

Equivalently, the irreversible fraction of intracellular exit is $24/36=0.6667$, so $18(0.6667)=12.00$ L/h. The balance also checks directly: uptake is $18(1.5)=27.00$ mg/h; efflux is $12(0.7500)=9.000$ mg/h; and metabolism plus biliary export is $24(0.7500)=18.00$ mg/h. The total exit, $27.00$ mg/h, matches uptake.

Worked Example: Strong Efflux Reduces Net Clearance

Consider hypothetical clearances $CL_{\mathrm{uptake}}=30$ L/h, $CL_{\mathrm{efflux}}=45$ L/h, $CL_{\mathrm{met}}=10$ L/h, and $CL_{\mathrm{bile}}=5$ L/h, with $C_{\mathrm{pl}}=2.0$ mg/L. Assume the same linear, single-pool, compatible-basis, quasi-steady conditions. Total intracellular exit clearance is $45+10+5=60$ L/h.

The intracellular concentration is:

C_{\mathrm{cell}} = \frac{30}{60}(2.0) =1.000\ \mathrm{mg/L}.

Metabolic and biliary removal total $(10+5)(1.000)=15.00$ mg/h. Dividing by $C_{\mathrm{pl}}$ gives $15.00/2.0=7.500$ L/h. The fraction escaping basolateral efflux is $15/60=0.2500$, and the product form agrees: $30(0.2500)=7.500$ L/h. Uptake is $30(2.0)=60.00$ mg/h; efflux returns $45.00$ mg/h, leaving $15.00$ mg/h for irreversible removal.

This example shows why uptake clearance alone cannot be substituted for net intrinsic clearance. A large uptake flux can coexist with modest net removal when much of the intracellular drug exits back to blood.

Worked Example: No Biliary Export and a Limiting Case

Suppose a hypothetical system has $CL_{\mathrm{uptake}}=8.0$ L/h, $CL_{\mathrm{efflux}}=2.0$ L/h, $CL_{\mathrm{met}}=6.0$ L/h, and $CL_{\mathrm{bile}}=0$ L/h. Let $C_{\mathrm{pl}}=0.50$ mg/L. Assume linear pathways, compatible concentration bases, one pool, and quasi-steady conditions. Total exit clearance is $2.0+6.0+0=8.0$ L/h, so the required positive-exit condition holds.

The concentration ratio is $8.0/8.0=1.000$, hence $C_{\mathrm{cell}}=0.50$ mg/L. Metabolic removal is $6.0(0.50)=3.00$ mg/h, and there is no biliary removal. Thus:

CL_{\mathrm{int,net}} = \frac{3.00\ \mathrm{mg/h}}{0.50\ \mathrm{mg/L}} =6.000\ \mathrm{L/h} = 8.0\left(\frac{6.0}{2.0+6.0+0}\right)\mathrm{L/h}.

If instead both $CL_{\mathrm{met}}$ and $CL_{\mathrm{bile}}$ were zero while $CL_{\mathrm{efflux}}>0$, the formula would yield $CL_{\mathrm{int,net}}=0$: uptake would be balanced entirely by return to blood. If all three exit clearances were zero, quasi-steady balance would not determine a finite intracellular concentration for positive uptake. The stated theorem therefore requires positive total exit clearance.

Why the Algebra Is Stable, and When to Use It

The quasi-steady result can also be checked against the dynamic mass balance. For constant plasma concentration and fixed clearances, substitute $A_{\mathrm{cell}}=V_{\mathrm{cell}}C_{\mathrm{cell}}$ to obtain a first-order linear differential equation. With $CL_{\mathrm{exit}}>0$, its solution approaches the quasi-steady value:

C_{\mathrm{cell}}(t) = \frac{CL_{\mathrm{uptake}}C_{\mathrm{pl}}}{CL_{\mathrm{exit}}} + \left[ C_{\mathrm{cell}}(0) - \frac{CL_{\mathrm{uptake}}C_{\mathrm{pl}}}{CL_{\mathrm{exit}}} \right] \exp\left(-\frac{CL_{\mathrm{exit}}}{V_{\mathrm{cell}}}t\right).

The exponential term decays because $CL_{\mathrm{exit}}/V_{\mathrm{cell}}>0$. The characteristic adjustment time is $V_{\mathrm{cell}}/CL_{\mathrm{exit}}$. A quasi-steady approximation is plausible when that time is short relative to the timescale over which plasma concentration or pathway clearances change. If the timescales are similar, or if an early transient is important, the dynamic mass balance should be retained rather than setting $dA_{\mathrm{cell}}/dt=0$.

The formula is useful because it separates two influences: how efficiently drug enters the cell, represented by $CL_{\mathrm{uptake}}$, and what fraction of intracellular exit is irreversible, represented by $(CL_{\mathrm{met}}+CL_{\mathrm{bile}})/CL_{\mathrm{exit}}$. It also clarifies a key contrast with a model that treats plasma disappearance as direct metabolism: in the present model, intracellular return to blood competes with irreversible removal. The algebra is not a replacement for the broader extended clearance architecture or for embedding clearance in an organ model.

This result has limits. Saturable transport or metabolism makes the clearances concentration-dependent, so a single constant fraction may not describe the full concentration range. Multiple intracellular pools, additional uptake routes, or unmodeled exits alter the balance. Biliary export is treated as irreversible removal from the modeled parent pool; if drug can return from bile to that pool, the return process must be represented. In each case, the appropriate mass balance must include the relevant fluxes before deriving a net clearance.

Diagnostics and Common Pitfalls

A useful diagnostic is to check mass balance numerically: at quasi-steady state, uptake rate must equal the sum of efflux, metabolic, and biliary rates. A mismatch often indicates an omitted pathway, inconsistent units, or a concentration basis that was not applied consistently. Also check that the calculated irreversible fraction is between zero and one when all clearances are nonnegative. A result outside this range signals an algebraic or parameter-definition problem.

Counting efflux as elimination. Basolateral efflux removes drug from the cell but returns parent drug to blood. It belongs in the denominator, but not in the numerator for irreversible parent-drug removal.
Using uptake clearance as net clearance. This implicitly assumes every molecule taken up is irreversibly removed. The correction is to multiply uptake clearance by the irreversible fraction of total intracellular exit.
Applying the formula outside its assumptions. With transient intracellular accumulation, nonlinear fluxes, or omitted exits, the quasi-steady linear expression need not apply. Use a balance that represents those conditions instead.
Ignoring the domain of the rate ratio. Net intrinsic clearance defined as removal rate divided by $C_{\mathrm{pl}}$ requires $C_{\mathrm{pl}}>0$. At zero plasma concentration that ratio is undefined, even if the coefficient expression has a finite algebraic value.

Key takeaway: Under linear kinetics, a single intracellular pool, compatible concentration definitions, and quasi-steady conditions, net intrinsic clearance equals uptake clearance times the fraction of intracellular exit that is metabolic or biliary. Basolateral efflux reduces that fraction because it returns parent drug to blood.

Check Your Understanding

Use the assumptions stated in each question, and keep rate units consistent.

Let uptake, efflux, metabolism, and biliary clearances be 10, 5, 3, and 2 L/h, respectively. What is net intrinsic clearance?
For the same clearances as in Question 1 and $C_{\mathrm{pl}}=2$ mg/L, calculate $C_{\mathrm{cell}}$ and verify the uptake and total exit rates.
If metabolism and biliary export are both zero but efflux is positive, what is the net intrinsic clearance under the model, and why?
Why is the quasi-steady approximation questionable when intracellular adjustment time is similar to the timescale of plasma concentration change?
Can the rate-divided-by-plasma-concentration definition be evaluated at $C_{\mathrm{pl}}=0$? Explain.

Solutions. 1. Total exit clearance is $5+3+2=10$ L/h, and the irreversible fraction is $(3+2)/10=0.5000$. Thus net intrinsic clearance is $10(0.5000)=5.000$ L/h. 2. The concentration ratio is $10/10=1$, so $C_{\mathrm{cell}}=2$ mg/L. Uptake is $10(2)=20$ mg/h. Efflux is $5(2)=10$ mg/h, and irreversible removal is $(3+2)(2)=10$ mg/h; total exit is 20 mg/h, matching uptake. 3. It is zero, because all intracellular drug exits through basolateral efflux and none is removed through the modeled irreversible pathways. 4. Intracellular concentration then may not track its quasi-steady value before plasma concentration changes materially; the dynamic mass balance is needed to represent the lag. 5. No. The defined ratio has zero in its denominator and is undefined at $C_{\mathrm{pl}}=0$; the theorem requires positive plasma concentration.